Add BrightSurf on Google Email

Weill Cornell Medicine


Report calls for using heated chemotherapy after colon cancer surgery to optimize patient survival

A consensus statement published in Annals of Surgical Oncology calls for heated chemotherapy after colon cancer surgery to optimize patient survival. The treatment, known as HIPEC, has shown promising results with a median survival of greater than 20 months compared to six-month survival with traditional intravenous chemotherapy.

SourceWeill Cornell Medicine·JournalAnnals of Surgical Oncology·DateNov 3, 2006